Phase III randomized controlled clinical study of UFT/LV [tegafur/uracil/folinic acid] therapy versus UFT/LV + PSK [polysaccharide-K] therapyfor Histological Stage IIIa and IIIb Colorectal Cancer

Trial Profile

Phase III randomized controlled clinical study of UFT/LV [tegafur/uracil/folinic acid] therapy versus UFT/LV + PSK [polysaccharide-K] therapyfor Histological Stage IIIa and IIIb Colorectal Cancer

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Polysaccharide K (Primary) ; Folinic acid; Tegafur/uracil
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Sep 2007 Status changed from initiated to recruiting.
    • 10 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top